FDA Approves First New Fibromyalgia Treatment in Over 16 Years
The FDA has approved Tonmya, a new treatment for fibromyalgia developed by Tonix Pharmaceuticals, marking the first new FDA-approved fibromyalgia drug in over 15 years. The drug is a once-daily sublingual tablet shown to significantly reduce pain in clinical trials. Following the announcement, Tonix's stock initially surged but then declined, reflecting market volatility and investor reactions.